True Wealth Design’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$651 Buy
+50
New +$569 ﹤0.01% 2115
2026
Q1
Sell
-5
Closed -$65 2706
2025
Q4
$65 Buy
+5
New +$62 ﹤0.01% 2392
2025
Q3
Sell
-8
Closed -$80 2725
2025
Q2
$80 Buy
8
+2
+33% +$20 ﹤0.01% 2293
2025
Q1
$57 Buy
+6
New +$63 ﹤0.01% 2348
2024
Q4
Sell
-651
Closed -$5.07K 1358
2024
Q3
$5.07K Buy
+651
New +$4.7K ﹤0.01% 552

Other funds holding ANGO

True Wealth Design's ANGO Position: Q2 2026 in Review

True Wealth Design opened a new position in AngioDynamics (ANGO) in Q2 2026: 50 shares worth $651. The stake represents ﹤0.01% of the portfolio and ranks #2115 among its holdings. This is a return to the name: True Wealth Design previously reported a position in ANGO as recently as Q4 2025.

True Wealth Design first reported a position in ANGO in Q3 2024 and has held it in 5 quarters since. The position peaked at $5.07K in Q3 2024. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • True Wealth Design held 50 shares of AngioDynamics worth $651 as of Q2 2026.
  • AngioDynamics was a new True Wealth Design position in Q2 2026.
  • AngioDynamics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2115 holding.
  • True Wealth Design first reported a position in AngioDynamics in Q3 2024 and has held it in 5 quarters since.
  • True Wealth Design's AngioDynamics position peaked at $5.07K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.